Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
about
Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysisAssociation between the PARP1 Val762Ala polymorphism and cancer risk: evidence from 43 studies.Lung cancer in womenThe effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysisXPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.Potentially functional polymorphisms in the ERCC2 gene and risk of esophageal squamous cell carcinoma in Chinese populations.Allele and genotype distributions of DNA repair gene polymorphisms in South Indian healthy population.Association between ERCC5 gene polymorphisms and breast cancer riskA Functional Polymorphism (rs10817938) in the XPA Promoter Region Is Associated with Poor Prognosis of Oral Squamous Cell Carcinoma in a Chinese Han Population.Association between XPG polymorphisms and stomach cancer susceptibility in a Chinese population.Capture-based next-generation sequencing reveals multiple actionable mutations in cancer patients failed in traditional testing.XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer.Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese populationPredictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studiesPolymorphisms in XPC, XPD and XPG DNA repair genes and leukemia risk in a Tunisian population.XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications.XPG Asp1104His polymorphism and gastrointestinal cancers risk: a meta-analysis.Molecular insights into the transcriptional regulatory role of thyroid hormones in ovarian cancer.Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: evidence based on a meta-analysis.XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies.Polymorphisms in 2 and 5 and Risk of Prostate Cancer: A Meta-Analysis and Systematic Review
P2860
Q28385328-B7A77512-B941-4CBA-BFA5-35DEDC0FF660Q28395032-CA72260C-A261-427C-9A35-AD101400E99FQ29248783-8C1BD5D8-C6E3-4E05-903F-6752FB7B7455Q33560417-B2EEAA18-6933-4688-AB75-0526CE54734DQ33911292-36F8DE63-C1D6-4EA3-BEF0-79086DF56052Q34162521-6E94B78B-6448-43C3-B7D5-3D744B874033Q34657153-1269EE8B-6A3E-4CF2-A391-E87F754A05C7Q35632371-146B24D6-2B52-465F-A79D-17345B424D7EQ36131135-E7819431-96F3-4752-837C-CCA896CC4FEDQ36797469-03FB93BD-E6B4-4247-9402-D10840B2B265Q36902969-3C19F61F-5E85-454B-A8CA-3279BD49674FQ36998361-E2166482-6C9D-4F0C-A4C9-E7C4FBA3AAA7Q37117165-0C7CAA49-F5A0-4F9C-9AA8-DDABAE4F7D2FQ37662309-8FF90179-A0A8-4802-830E-40AE870521DEQ38368993-FC9CE39D-5796-4CC8-8BD3-F697C21131EFQ38977352-BDCB8B5B-FD48-4822-BA89-4CDD2582EF32Q40053152-54F39941-F983-432F-A852-39915BD79F3FQ42045954-768F9BC7-943B-450D-B47B-78A5FC54A14AQ47824971-58145816-4B18-4707-A762-441C81F68C08Q53138063-62CCC883-2769-47AD-A8D4-3FBF809DA255Q55101935-04820DB9-59C6-4A5F-9AAE-815F9B8F0EE6Q57109501-BBF5680E-22CD-4B3B-87BA-8234DEC20D81
P2860
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis
@nl
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
@ast
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
@en
type
label
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis
@nl
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
@ast
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
@en
prefLabel
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis
@nl
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
@ast
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
@en
P2093
P2860
P3181
P1433
P1476
Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis
@en
P2093
Kai-Qin Xia
Li-Xin Qiu
Mei-Ling Zhu
Mengyun Wang
Qing-Yi Wei
Ting-Yan Shi
Zhi-Gang Cao
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0036293
P407
P50
P577
2012-07-18T00:00:00Z